<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJAnes</journal-id><journal-title-group><journal-title>Open Journal of Anesthesiology</journal-title></journal-title-group><issn pub-type="epub">2164-5531</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojanes.2022.1212031</article-id><article-id pub-id-type="publisher-id">OJAnes-121873</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Management of Arterial Hypotension Induced by Spinal Anesthesia during Cesarean Section at the Parakou University Hospital in Benin in 2020: Ephedrine versus Noradrenaline
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Blaise</surname><given-names>Adelin Tchaou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Samaké</surname><given-names>Broulaye Massaoulé</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dossou</surname><given-names>Bodjrènou Marjolaine Oriane</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Brouh</surname><given-names>Yapo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Department of Intensive Care Unit at the University Hospital Gabriel Touré, Bamako, Mali</addr-line></aff><aff id="aff3"><addr-line>Department of Anesthesia-Intensive Care and Pediatric Emergencies, Mother-Child Hospital of Bingerville, Bingerville, 
C&amp;amp;ocirc;te d’Ivoire</addr-line></aff><aff id="aff1"><addr-line>Department of Anesthesia-Intensive Care and Emergencies, University and Departmental Hospital Center of Borgou/Alibori, Parakou, Benin</addr-line></aff><pub-date pub-type="epub"><day>20</day><month>12</month><year>2022</year></pub-date><volume>12</volume><issue>12</issue><fpage>351</fpage><lpage>367</lpage><history><date date-type="received"><day>16,</day>	<month>October</month>	<year>2022</year></date><date date-type="rev-recd"><day>18,</day>	<month>December</month>	<year>2022</year>	</date><date date-type="accepted"><day>21,</day>	<month>December</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution-NonCommercial International License (CC BY-NC).http://creativecommons.org/licenses/by-nc/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Background:</b> Spinal anesthesia (SA) is a preferred anesthetic technique for childbirth through caesarean section. It causes a sympathetic block responsible for low blood pressure which can be prevented or treated with vasopressors. 
  <b>Aim:</b> This research aims to compare the effect of Noradrenaline with that of Ephedrine in the management of arterial hypotension caused by SA during Caesarean act. 
  <b>Study method:</b> It was a cross-sectional study with two comparative settings which took place at the Teaching hospital of Parakou from April 15
  <sup>th</sup> to August 15
  <sup>th</sup> 2020. It included all parturients who underwent a caesarian act and received spinal anesthesia. To prevent hypotension two groups were formed. The first group parturient received Noradrenaline (10 γ) as prophylactic and the second group received Ephedrine (10 mg) before anesthesia. The main evaluation criteria were the time before the hypotension occurs and, the secondary endpoint was the number of hypotension episode. The two groups were compared using the usual statistical tests. The study received the approval of the Local Ethical committee of University of Parakou. 
  <b>Results:</b> Two hundred and four parturients were compiled with 102 in each group. The mean age was 28.37 &#177; 6.15 years with extremes of 16 and 45 years. The main indications for Caesarean section were respectively iterative Caesarean section (46.57%) for scheduled Caesarean section and acute fetal distress (15.69%) for emergency Caesarean section. The incidence of hypotension was 38.24%. The mean delay of occurrence of hypotension was significantly longer in adrenaline group (19.90 min) than ephedrine group (12.53 min) with P = 0.001. According to the secondary endpoint the number of episodes of hypotension, number of tachycardia, and the total doses of each vasopressor were significantly lower in adrenaline group than in the ephedrine group. 
  <b>Conclusion:</b> The use of Noradrenaline according to the established protocol demonstrated its efficiency compared with Ephedrine in the management of hypotension after spinal anesthesia.
 
</p></abstract><kwd-group><kwd>Spinal Anesthesia</kwd><kwd> Caesarean Section</kwd><kwd> Hypotension</kwd><kwd> Ephedrine</kwd><kwd> Noradrenaline</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Childbirth is the physical and psychological culmination of pregnancy. This is a way through which it leads to the reality of the childbirth and which is usually done via the downer route that is vaginal. However, in thousands of cases, and for multiple reasons related to either the mother or the newborn, the outcome is via the upper route: it is the caesarean act [<xref ref-type="bibr" rid="scirp.121873-ref1">1</xref>]. Thus, several anesthetic techniques are used to perform the cesarean act safely. Spinal anesthesia (SA) is the technique of choice for Caesarean delivery of parturient classified as ASA 1 and 2. It is an anesthetic technique that exposes the pregnant woman to fewer complications compared with general anesthesia (GA) [<xref ref-type="bibr" rid="scirp.121873-ref1">1</xref>]. By 2014, SA accounted for 60% of anesthetic techniques used for caesarean sections according to the French Society of Anesthesia and Intensive Care (SFAR) [<xref ref-type="bibr" rid="scirp.121873-ref2">2</xref>]. This anesthetic technique has three main effects: sympathetic block, sensory block and motor block. The sympathetic block is the major element that conditions hemodynamic stability and is responsible for low blood pressure, which secondarily leads to a decrease in uteroplacental flow [<xref ref-type="bibr" rid="scirp.121873-ref3">3</xref>]. This finding was made by Cowper et al. who reported that SA leads to maternal hypotension in 50% - 80% of cases [<xref ref-type="bibr" rid="scirp.121873-ref3">3</xref>]. Similarly, other authors have shown that SA-induced hypotension is thought to result from preganglionic sympathetic block and therefore vasodilation [<xref ref-type="bibr" rid="scirp.121873-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref5">5</xref>].</p><p>Numerous preventive and curative measures have been developed [<xref ref-type="bibr" rid="scirp.121873-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref7">7</xref>], including the use of vasoconstrictors [<xref ref-type="bibr" rid="scirp.121873-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref8">8</xref>]. Two sympathomimetic agents have been widely studied in different protocols. Ephedrine was the first vasopressor used in the management of post SA-induced hypotension, but it is not without consequences and is thought to be responsible for neonatal acidosis [<xref ref-type="bibr" rid="scirp.121873-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref8">8</xref>].</p><p>Phenylephrine is currently the recommended first-line vasopressor with fewer side effects [<xref ref-type="bibr" rid="scirp.121873-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref11">11</xref>]. In obstetrics, there are other molecules in common practice that act on cardiac output and blood pressure, the principal one being Noradrenaline (NA). In 2015, Ngan Keeet al., as well as other authors have reported using preventive norepinephrine versus phenylephrine similar effects of the two products [<xref ref-type="bibr" rid="scirp.121873-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref15">15</xref>]. In Benin, it was assumed that Norepinephrine and Phenylephrine had similar effects and that Phenylephrine was more difficult to access because of its high cost: 3500 FCFA (6.35 US dollars) by ampoule compared to 1200 FCFA (2.18 US dollars) by ampoule for Noradrenaline, it seems appropriate to initiate this study whose aim is to compare the effect of Noradrenaline to that of Ephedrine in the management of SA-induced hypotension during caesarean section.</p></sec><sec id="s2"><title>2. Patients and Method</title><sec id="s2_1"><title>2.1. Study Framework</title><p>The operating rooms of the Gynecology-Obstetrics Department of the University Hospital of Parakou in Benin were used as a study setting. Six (6) obstetrician-gynecologists, 3 anesthesiologists and 18 nurse anesthetists are involved in this sector.</p></sec><sec id="s2_2"><title>2.2. Study Method</title><p>Type and period of study: This was a non-randomized semi-experimental study comparing two intervention strategies with data collection carried out over a period of 5 months from April 15 to August 15, 2020. The protocol was submitted to the Ethics Committee of the Faculty of Medicine and approved according to the number (REF 0318/CLERB-UP/P/SP/R/SA).</p><p>Study population:It was made up of parturient who had undergone caesarean section under spinal anesthesia in the operating bloc of the Gynecology-Obstetrics Department of the Parakou University Hospital during the period of the study.</p><p>Inclusion criteria: Parturient classified as ASA 1 and 2 who underwent caesarean section under spinal anesthesia during the period of the study and who gave their informed consent or that of a close relative to participate in the study were included.</p><p>Exclusion Criteria:Patients who underwent caesarean section under spinal anesthesia and did not receive either of the two vasopressors used in the study were excluded.</p><p>Criteria for non-inclusion:Patients with high blood pressure (pre-existing or gestational), pre-eclampsia (regardless of severity) and who had a caesarean section were not included. The variables studied were of two orders.</p><p>The dependent variable:the occurrence of hypotension after administration of the local anesthetic (Bupivaca&#239;ne).</p><p>The independent variables: grouped into sociodemographic data, clinical data, data related to the caesarean section, data related to the anesthesia and evolutionary data under vasopressors.</p><p>&#183; Sociodemographic data: age, socio-professional category and marital status.</p><p>&#183; Clinical data: patient history, temperature, blood pressure (BP), heart rate (HR), pulsed oxygen saturation (SpO<sub>2</sub>), respiratory rate (RR), weight, height, body mass index (BMI) and ASA classification.</p><p>&#183; Data related to Caesarean section: indication for Caesarean section, type of Caesarean section, time between induction and incision, time between incision and extraction, and duration of the procedure.</p><p>&#183; Data related to anesthesia: pre-anesthetic consultation, qualification of the anesthetist, local anesthetic and adjuvants used, site of injection of the local anesthetic, plasma volume expanders and their doses, vasopressors (Ephedrine or Noradrenaline) and the doses used.</p><p>&#183; Evolutionary data: vital constants (temperature, BP, RR, SpO<sub>2</sub>, and HR), time to onset of hypotension after spinal anesthesia and number of hypotension episodes, number of boluses of the vasopressor and total dose used, and side effects observed.</p></sec><sec id="s2_3"><title>2.3. Method of Data Collection</title><p>Collection tools:we used the patients’ medical records, a pre-established survey form and the multipara meter monitor for intraoperative monitoring.</p><p>Collection technique:The data of each patient were collected by direct observation using a questionnaire that we filled in after consulting the medical records in preoperative care and follow-up in the operating theatre in intraoperative care.</p><p>Sampling procedure:A systematic recruitment of all patients who had a scheduled or emergency caesarean section during the study period and who met our inclusion criteria was carried out.</p><p>Collection procedure: On arrival in the operating room, the patients were positioned on the operating table in a lying position with left lateral inclination and the monitoring begun. Basic hemodynamic measurements: TA, HR, SpO<sub>2</sub>, RR, ETCO<sub>2</sub> electrocardiography (ECG) were recorded using a multi parameter monitor. After measurement of the basic hemodynamic variables and complete disinfection of the puncture site, a 25 Gauge (25 G) lumbar puncture needle was inserted via a needle introducer in the interspinous space between L3 - L4 or L4 - L5 and exceptionally between L2 - L2 in the sitting position. After confirmation of the free flow of cerebrospinal fluid, a mixture of 7.5 - 10 mg of 0.5% hyperbaric Bupivacaine and 200 γ of morphine was injected intrathecally, and the patient was returned to a supine position. The quality of the spinal anesthesia was evaluated by three criteria: sympathetic block, level of sensory block, and motor block. The sensory block was sought by the “hot-cold” test, while the motor block was assessed by the BROMAGE score. At the beginning of the intrathecal injection, rapid intravenous therapy with lactated ringer’s solution or saline solution 0.9% was carried out using a large diameter catheter (G18 or G20 catheter). The choice of vasopressor to be administered to each patient and the blood pressure management protocol was recorded on the survey form and made available to the anesthetist. Thus, two groups with equal numbers of parturients were obtained, depending on the type of vasopressor used. The presentation of the two vasopressors and the administration protocol were as follows:</p><p>&#183; Noradrenaline tartrate 2 mg/mL (Levophied&#174;, Hospira, Inc., Lake Forest, IL, USA) 1 mg/0.5mL diluted in 10 mL syringes of SS 0.9% to give 10 gamma per mL.</p><p>&#183; Ephedrine Sulphate 30 mg/mL (Ephedrine Sulphate&#174;, Akorn, Inc., India), diluted in 10 mL syringes of SS 0.9% to give 3mg/mL Ephedrine.</p><p>- Each patient in the NA group (Noradrenaline group) had received an intravenous prophylactic bolus of Noradrenaline 10 γ at during the intrathecal injection of the local anesthetic, plus rescue boluses of Noradrenaline 10 γ whenever maternal systolic blood pressure was less than or equal to 90 mm Hg.</p><p>- Each patient in group E (Ephedrine group) received a prophylactic bolus of 10 mg of Ephedrine during the intrathecal injection of the local anesthetic, plus rescue boluses of 10 mg of Ephedrine whenever maternal systolic blood pressure was less than or equal to 90 mm Hg.</p><p>The number of boluses of vasopressors used apart from the prophylactic doses was recorded and considered to be the main outcome of the study. Heart Rate (beats/min) and Blood Pressure (mm Hg) were recorded every 2 min after intrathecal injection until delivery of the baby and then every 5 min until the end of the surgery.</p><p>Endpoint</p><p>The primary endpoint was the delay since vasopressor injection and the hypotension occurrence. Secondary we record the number of hypotension episodes, the tachycardia episodes, the need of vasopressor rescue, and the total doses of the vasopressor.</p><p>The side effects as hypertension, bradycardia, nausea, vomiting, headache, vertigo and other were recorded.</p></sec><sec id="s2_4"><title>2.4. Data Processing and Analysis</title><p>All the data were entered twice in the EPI data 3.1 software and the data analyses using the Epi Info v7.2 software from the Center of Disease Control (CDC). Text entry and the creation of tables and graphs were done using Microsoft Office&#174; 2013. The qualitative variables were expressed in terms of frequency, percentage with a 95% confidence interval. The quantitative variables were expressed in terms of mean and standard deviation in the case of normal distribution and in terms of median with interquartile range in the opposite case. The Chi-square test or the Fisher exact test was used to compare the percentages. The Student’s t-test was used to compare averages. For these comparisons the significance threshold will be set at 0.05% or 5%.</p></sec></sec><sec id="s3"><title>3. Results</title><p>Sociodemographic data</p><p>During the period of study, 1025 parturients consulted the Gynecology-Obstetrics Department of the University Hospital of Parakou and among them 797 gave birth (77.76%). Three hundred and fourteen deliveries were performed by caesarean section, representing 39.40% of deliveries. According to our inclusion criteria we collected 204 patients (25.60%), divided into 2 groups of 102 patients for Noradrenaline and Ephedrine respectively.</p><p>The average age of the study population was 28.37 &#177; 6.15 years with extremes of 16 and 45 years. The most represented age group was between 26 and 35 years old. Married or cohabiting women accounted for 94.60% of the study population (n = 193). Housewives numbered 90% or 44.17% of the sample. The data on other specific variables were described in the second column in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>Of the 204 parturients operated on, 159 patients (77.94%) had an ASA 1 score and 45 of them (22.06%) had an ASA 2 score.</p><p>Duration of the different phases of the Caesarean section</p><p>The average duration of the induction-incision phase (minutes) was 12.58 &#177; 7.36 with extremes of 2 and 75 minutes. The average duration of the incision-extraction phase (minutes) was 4.44 &#177; 4.42 with extremes of 1 and 34 minutes. The mean duration of the caesarean section (minutes) was 38.34 &#177; 18.04 with extremes of 13 and 153 minutes.</p><p>Data related to anesthesia</p><p>&#183; Pre-anesthetic consultation and qualification of the anesthetist</p><p>In our series, 110 parturients (53.92%) got a pre-anesthetic consultation before the caesarean section was performed. The consultation was performed in 99.02% (n = 202) by the anesthetist nurses under cover of the anesthetist and intensive care doctors. On the other hand, 94 (46.08%) got a pre-anesthetic visit before the procedure was carried out.</p><p>&#183; Anesthetic drugs and adjuvants used</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Characteristics of parturient at baseline</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Population</th><th align="center" valign="middle" >Noradrenaline</th><th align="center" valign="middle" >Ephedrine</th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" >Age (years)</td><td align="center" valign="middle" >28.37 &#177; 6.15</td><td align="center" valign="middle" >26.71 (18 - 36)</td><td align="center" valign="middle" >29.67 (20 - 41)</td><td align="center" valign="middle" >0.047</td></tr><tr><td align="center" valign="middle" >Weigth (Kg)</td><td align="center" valign="middle" >72.30 &#177; 11.70</td><td align="center" valign="middle" >70.24 (54 - 138)</td><td align="center" valign="middle" >76.19 (48 - 120)</td><td align="center" valign="middle" >0.121</td></tr><tr><td align="center" valign="middle" >Height (m)</td><td align="center" valign="middle" >1.62 &#177; 0.04</td><td align="center" valign="middle" >1.61 (1.56 - 1.66)</td><td align="center" valign="middle" >1.63 (1.52 - 1.75)</td><td align="center" valign="middle" >0.103</td></tr><tr><td align="center" valign="middle" >Body mass Index (BMI)</td><td align="center" valign="middle" >27.33 &#177; 3.86</td><td align="center" valign="middle" >27.06 (21.63 - 53.91)</td><td align="center" valign="middle" >28.44 (19.72 - 43.87)</td><td align="center" valign="middle" >0.285</td></tr><tr><td align="center" valign="middle" >Temperature</td><td align="center" valign="middle" >36.57 &#177; 0.53</td><td align="center" valign="middle" >36.56 (36 - 37.7)</td><td align="center" valign="middle" >36.69 (36 - 38)</td><td align="center" valign="middle" >0.366</td></tr><tr><td align="center" valign="middle" >Pulse</td><td align="center" valign="middle" >93.49 &#177; 16.95</td><td align="center" valign="middle" >94.86 (68 - 120)</td><td align="center" valign="middle" >96.77 (66 - 145)</td><td align="center" valign="middle" >0.691</td></tr><tr><td align="center" valign="middle" >Systolic Blood Pressure</td><td align="center" valign="middle" >127.17 &#177; 11.20</td><td align="center" valign="middle" >129.86 (102 - 141)</td><td align="center" valign="middle" >121.14 (92 - 143)</td><td align="center" valign="middle" >0.005</td></tr><tr><td align="center" valign="middle" >Diastolic blood pressure</td><td align="center" valign="middle" >76.20 &#177; 11.08</td><td align="center" valign="middle" >75.24 (60 - 90)</td><td align="center" valign="middle" >73.04 (36 - 94)</td><td align="center" valign="middle" >0.450</td></tr><tr><td align="center" valign="middle" >Breath frequency</td><td align="center" valign="middle" >18.20 &#177; 1.68</td><td align="center" valign="middle" >17.62 (14 - 22)</td><td align="center" valign="middle" >18.32 (16 - 22)</td><td align="center" valign="middle" >0.085</td></tr><tr><td align="center" valign="middle" >Oxygen Saturation</td><td align="center" valign="middle" >98.60 &#177; 1.12</td><td align="center" valign="middle" >98.76 (96 - 100)</td><td align="center" valign="middle" >98.60 (95 - 100)</td><td align="center" valign="middle" >0.573</td></tr><tr><td align="center" valign="middle" >Type of caesarian</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.071</td></tr><tr><td align="center" valign="middle" >Planned</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >8 (38.10%)</td><td align="center" valign="middle" >36 (63.16%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Emergency</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >13 (61.90%)</td><td align="center" valign="middle" >21 (36.84%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Caesarian duration (min)</td><td align="center" valign="middle" >40.37 (18 - 102)</td><td align="center" valign="middle" >40.52 (18 - 78)</td><td align="center" valign="middle" >40.18 (20 - 102)</td><td align="center" valign="middle" >0.938</td></tr></tbody></table></table-wrap><p>The local anesthetic used in the series was 0.50% hyperbaric Bupivacaine. The average dose administered was 9.95 &#177; 0.31 milligrams, with extremes of 8 and 10 milligrams. The adjuvant used in our series was morphine at a dose of 200 micrograms.</p><p>&#183; Plasma volume expanders</p><p>For vascular pre-filling, Ringer Lactate was used in 98.04% (n = 200) and SS 9‰ was used in 1.96% of cases (n = 4). On the other hand, during co-filling, Ringer lactate was used in 97.55% of cases (n = 199) and SS% was used in 2.45% of cases (n = 5).</p><p>&#183; Vasopressor doses used</p><p>The two vasopressors used in our series were Ephedrine and Noradrenaline. The average dose of Ephedrine (mg) used was 18.73 &#177; 9.41 with extremes of 10 - 50 mg. The average dose of Noradrenaline (mcg) used was 12.48 &#177; 4.56 with extremes of 10 - 30 mcg.</p><p>Outcome data</p><p>Incidence of bradycardia, tachycardia, hypotension and increased blood pressure</p><p>Hypotension appeared in 38.24% of cases (n = 78) after the prophylactic doses of vasopressor with an average onset time of 14.62 &#177; 8.38 minutes and extremes 1 and 46 minutes.</p><p>In the series of the study, additional boluses were administered to 20 parturients (19.60%) in the Noradrenaline group and 59 parturients (57.84%) in the Ephedrine group.</p><p>When we consider the patients with hypotension (n = 78) the data of each group were compared in <xref ref-type="table" rid="table2">Table 2</xref>. The parturient in adrenaline group was significantly younger and had a high baseline systolic blood pressure.</p><p>The primary endpoint parturient in Noradrenaline group had significantly long delay of hypotension occurrence, low number of hypotension episodes. On the other hand, they had received low doses of vasopressors and less episodes of tachycardia. The side effects were the same in both groups. Those data were summarized in <xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="table" rid="table3">Table 3</xref>.</p><p>&#183; Hypotension and maternal parameters upon installation</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparison of two groups according to endpoint in patients with hypotension</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Noradrenaline</th><th align="center" valign="middle" >Ephedrine</th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" >Delay for hypotension occurrence</td><td align="center" valign="middle" >19.90 (10 - 46)</td><td align="center" valign="middle" >12.53 (1 - 31)</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >Number episodes of hypotension</td><td align="center" valign="middle" >1.05 (1 - 2)</td><td align="center" valign="middle" >1.61 (1 - 5)</td><td align="center" valign="middle" >0.004</td></tr><tr><td align="center" valign="middle" >Number of hypertension episodes</td><td align="center" valign="middle" >0.05 (0 - 1)</td><td align="center" valign="middle" >0.21 (0 - 2)</td><td align="center" valign="middle" >0.113</td></tr><tr><td align="center" valign="middle" >Number of bradycardia episodes</td><td align="center" valign="middle" >0.10 (0 - 1)</td><td align="center" valign="middle" >0.02 (0 - 1)</td><td align="center" valign="middle" >0.121</td></tr><tr><td align="center" valign="middle" >Number of tachycardia episodes</td><td align="center" valign="middle" >0.10 (0 - 1)</td><td align="center" valign="middle" >0.98 (0 - 5)</td><td align="center" valign="middle" >0.002</td></tr><tr><td align="center" valign="middle" >Number of vassopressor bolus</td><td align="center" valign="middle" >1.00 (0 - 2)</td><td align="center" valign="middle" >1.54 (1 - 4)</td><td align="center" valign="middle" >0.002</td></tr><tr><td align="center" valign="middle" >Total dose of each vasopressor</td><td align="center" valign="middle" >20.48 (20 - 30)</td><td align="center" valign="middle" >25.44 (20 - 50)</td><td align="center" valign="middle" >0.003</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Comparison of the side effects in two groups</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Noradrenaline</th><th align="center" valign="middle" >Ephedrine</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle" >Side effects</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.510</td></tr><tr><td align="center" valign="middle" >Nausea</td><td align="center" valign="middle" >4 (57.14%)</td><td align="center" valign="middle" >9 (32.14%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >0 (0.00%)</td><td align="center" valign="middle" >6 (21.43%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Frissons</td><td align="center" valign="middle" >2 (28.57%)</td><td align="center" valign="middle" >5 (17.86%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Headaches</td><td align="center" valign="middle" >1 (14.29%)</td><td align="center" valign="middle" >7 (25.00%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Vertigo</td><td align="center" valign="middle" >0 (0%)</td><td align="center" valign="middle" >1 (3.57%)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Relationship between hypotension and maternal parameters upon installation</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >N</th><th align="center" valign="middle"  colspan="2"  >Hypotension</th><th align="center" valign="middle"  rowspan="2"  >RP</th><th align="center" valign="middle"  rowspan="2"  >IC<sub>95%</sub></th><th align="center" valign="middle"  rowspan="2"  >P</th></tr></thead><tr><td align="center" valign="middle" >n</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >SBP</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.008</td></tr><tr><td align="center" valign="middle" >&gt;125</td><td align="center" valign="middle" >121</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >30.58</td><td align="center" valign="middle" >0.62</td><td align="center" valign="middle" >0.44 - 0.87</td></tr><tr><td align="center" valign="middle" >≤125</td><td align="center" valign="middle" >83</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >49.48</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Heart rate</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.929</td></tr><tr><td align="center" valign="middle" >&gt;80</td><td align="center" valign="middle" >155</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >38.06</td><td align="center" valign="middle" >0.98</td><td align="center" valign="middle" >0.65 - 1.47</td></tr><tr><td align="center" valign="middle" >≤80</td><td align="center" valign="middle" >49</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >38.78</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >BMI</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="4"  >0.017</td></tr><tr><td align="center" valign="middle" >Obesity (≥30)</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >57.14</td><td align="center" valign="middle" >1.30</td><td align="center" valign="middle" >0.81 - 2.08</td></tr><tr><td align="center" valign="middle" >Overweight (25 - 29.99)</td><td align="center" valign="middle" >135</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >31.85</td><td align="center" valign="middle" >0.72</td><td align="center" valign="middle" >0.46 - 1.13</td></tr><tr><td align="center" valign="middle" >Normal (18.50 - 24.99)</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >44.12</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p><xref ref-type="table" rid="table4">Table 4</xref> presents the relationship between the occurrence of hypotension and maternal parameters at the time of installation.</p><p>&#183; Hypotension and time interval during the operation</p><p>There was a link between the onset of hypotension and the delay between induction and incision. <xref ref-type="table" rid="table5">Table 5</xref> shows the relationship between hypotension and time interval during the operation.</p></sec><sec id="s4"><title>4. Discussion</title><p>Sociodemographic data</p><p>&#183; Frequency of caesarean section</p><p>During the study period, we recorded 797 deliveries, of which 314 were cesarean sections (39.39%). The rate of cesarean delivery in the study is identical to that reported by Mongbo et al. who in a study conducted in 2016 in Cotonou had reported 37.6% of cesarean cases [<xref ref-type="bibr" rid="scirp.121873-ref16">16</xref>]. On the other hand, Atad&#233; et al. in a study carried out in the same hospital in 2004, reported a caesarean section rate of 24.51% [<xref ref-type="bibr" rid="scirp.121873-ref17">17</xref>]. The high rates of cesarean section observed in this study and in</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Relationship between hypotension and time interval during the operation</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  rowspan="2"  >N</th><th align="center" valign="middle"  colspan="2"  >Hypotension</th><th align="center" valign="middle"  rowspan="2"  >RP</th><th align="center" valign="middle"  rowspan="2"  >IC<sub>95%</sub></th><th align="center" valign="middle"  rowspan="2"  >P</th></tr></thead><tr><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Time between induction and incision</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.015</td></tr><tr><td align="center" valign="middle" >&gt;15</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >54.35</td><td align="center" valign="middle" >1.62</td><td align="center" valign="middle" >1.15 - 2.29</td></tr><tr><td align="center" valign="middle" >≤15</td><td align="center" valign="middle" >158</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >33.54</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Time between incision and extraction</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.163</td></tr><tr><td align="center" valign="middle" >&gt;5</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >47.73</td><td align="center" valign="middle" >1,34</td><td align="center" valign="middle" >0.92 - 1.95</td></tr><tr><td align="center" valign="middle" >≤5</td><td align="center" valign="middle" >160</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >35.63</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Duration of the intervention</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle"  rowspan="3"  >0.663</td></tr><tr><td align="center" valign="middle" >&gt;35</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >40.45</td><td align="center" valign="middle" >1.11</td><td align="center" valign="middle" >0.78 - 1.57</td></tr><tr><td align="center" valign="middle" >≤35</td><td align="center" valign="middle" >115</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >36.52</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>the Mongbo study compared to the Atad&#233; study could be explained by the fact that free cesarean section has become a reality in Benin since 2006.</p><p>&#183; Age</p><p>The average age in our study was 28.37 &#177; 6.15 years with extremes of 16 and 45 years, and the most represented age group was that of patients aged 26 to 35 years (49.51%). This age range corresponds to the optimal age of fertility and this result was similar to those reported by Ali Elnabtity et al. in Egypt 2018 and Dyer et al. in South Africa in 2010 which were 27.04 &#177; 4.5 years and 27.1 &#177; 3.7 years respectively [<xref ref-type="bibr" rid="scirp.121873-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref19">19</xref>]. On the other hand, in Liege, Belgium, the study conducted by Lecoq et al. in 2010 found a mean age of 39 years justified by the high frequency of late pregnancies often at risk requiring cesarean section for delivery [<xref ref-type="bibr" rid="scirp.121873-ref20">20</xref>]. We did not note any significant differences in age between the parturients of the two groups.</p><p>Clinical data</p><p>&#183; ASA score</p><p>In the present study, 77.94% of parturients (n = 159) had an ASA 1 score. The same finding was made by Demb&#233;l&#233; et al. in Mali (53.3%) [<xref ref-type="bibr" rid="scirp.121873-ref21">21</xref>]. In contrast, in France in 2015, Bordes et al. had reported that more than half of their patients had an ASA class greater than or equal to 2 [<xref ref-type="bibr" rid="scirp.121873-ref22">22</xref>]. This difference could be explained by the youth of our study population and young subjects being a prior carrier of less comorbidities.</p><p>&#183; Weight</p><p>The average weight of the parturients was 72.30 &#177; 11.70 kg. This finding was also made by Xian Wang et al. in 2018 in China who had reported in their study a mean weight of 76.5 &#177; 8.1 kg [<xref ref-type="bibr" rid="scirp.121873-ref23">23</xref>]. In contrast, Lecoq in Liege had reported a mean weight of 65 &#177; 10 kg [<xref ref-type="bibr" rid="scirp.121873-ref20">20</xref>]. This difference could be explained by the eating habits and lifestyle in each region. However, the excess weight noted in the different studies can easily be explained by hormonal impregnation responsible for water retention and consequently weight gain. This excess weight is confirmed by the average BMI of the parturients in the series, which was 27.33 &#177; 3.86 kg/m<sup>2</sup>, and that of Vallejo et al. in a study carried out in the United States (33.6 &#177; 6.6 kg/m<sup>2</sup>) [<xref ref-type="bibr" rid="scirp.121873-ref24">24</xref>].</p><p>Data related to cesarean section</p><p>&#183; Phases of the cesarean section</p><p>The mean time from induction to incision was 12.58 &#177; 7.36 minutes. There was a significant difference (P &lt; 0.001) between the two groups with 12.82 and 12.34 min for the NA group and the E group, respectively. This difference could be explained by the delay in the onset of sensory block, related to the number of protein receptors (binding to α-1-acid glycoprotein (AGA)) to which Bupivacaine binds for inhibition of nerve impulse transmission along the axonal lipid membrane, a factor that varies from one individual to another and independently of the administration of the vasopressor.</p><p>&#183; Time between incision and extraction</p><p>The mean time from incision to extraction was 4.44 &#177; 4.42 minutes. There was a significant difference (P &lt; 0.001) between the two groups with 4.95 and 3.93 for the NA and E groups respectively. This difference could be explained by the ability and experience of the obstetrician to quickly perform the fetal extraction, this being independent of the vasopressor used.</p><p>&#183; Duration of the procedure</p><p>The average procedure time in the study was 38.34 &#177; 18.04 minutes. This result differs from that of Ali Elnabtity et al. who reported a mean duration of 50.1 &#177; 6.25 minutes [<xref ref-type="bibr" rid="scirp.121873-ref19">19</xref>]. This difference could be explained by the fact that Ali Elnabtity’s study only involved scheduled cesarean sections that are performed outside the emergency context.</p><p>Data related to anesthesia</p><p>&#183; Frequency of spinal anesthesia</p><p>Out of 314 cases of cesarean section, 280 were performed under spinal anesthesia, i.e. 89.17%. This high rate of cesarean section under spinal anesthesia is intended to avoid complications related to general anesthesia. Indeed, the pregnant woman in the third trimester being considered as a subject with a full stomach, whether in emergency surgery or in scheduled surgery, is prone to many complications when the technique proposed in case of general anesthesia. Thus, hormonal impregnation and the decrease in pulmonary compliance during pregnancy are responsible for edema and hyper vascularization of the upper aerodigestive tract with a consequent increased incidence of difficult intubation. In contrast to this technique, spinal anesthesia offers the advantage of preserving the freedom of the airways during delivery and also allows the woman to experience this delivery in the same way as a vaginal delivery.</p><p>&#183; Frequency of low blood pressure</p><p>Like any anesthetic technique, spinal anesthesia is not without consequences. Indeed, it induces three types of blocks: the sympathetic block, the sensory block and the motor block. The sympathetic block is responsible for a pharmacological arterial hypotension. Thus, in the present study, out of 204 patients, 78 showed arterial hypotension, i.e. a rate of 38.24%. Our result is far lower than those observed in the literature where the rate of arterial hypotension induced by spinal anaesthesia is estimated to be between 55% and 90% [<xref ref-type="bibr" rid="scirp.121873-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref26">26</xref>]. The systematic use of a prophylactic dose of vasopressor in our methodology could be the basis of this result with a low rate of arterial hypotension. The anticipation of management by the anesthesiologists through prophylactic doses of vasopressors is an attitude to be promoted and generalized to all the centers in Benin in order to improve the hemodynamic state of the patients during spinal anesthesia.</p><p>Anesthetic drugs and injection site</p><p>Hyperbaric Bupivacaine 0.50% was used with every patient at a mean dose of 9.95 &#177; 0.31 milligrams. Bupivacaine is a local anesthetic that reversibly blocks nerve conduction; moreover, due to its physicochemical properties, it has a duration of action of 3h - 3h 30 minutes, which allows sufficient analgesia during cesarean section, which is generally a medium-length procedure (45 minutes to 1 hour). Also the smaller volume of CSF in pregnant women (&lt;1000 mL) justifies these low doses administered intrathecally [<xref ref-type="bibr" rid="scirp.121873-ref17">17</xref>].</p><p>Time to onset of arterial hypotension</p><p>The mean time to onset of hypotension was 14.62 &#177; 8.38 minutes. We had no significant difference between the two groups (P = 0.513). However, the mean time to hypotension in the E group was higher (8.51 minutes) than in the NA group (4.10 minutes); this may be explained by differences in the pharmacokinetic properties of the 2 vasopressors (short onset and duration of action of norepinephrine compared to ephedrine) [<xref ref-type="bibr" rid="scirp.121873-ref11">11</xref>].</p><p>Filling fluids and quantities</p><p>LR was used in 98% of cases for vascular filling in our study. This could be explained not only by its power of volume expansion [<xref ref-type="bibr" rid="scirp.121873-ref27">27</xref>], but especially the absence of risk of occurrence of hyperchloremic acidosis observed in case of use of SS 0.9% or allergic reactions in case of use of macromolecules.</p><p>- Qualification of the anesthetist</p><p>In this study, the majority of anesthetic procedures (99.02%) were performed by certified nurse anesthetists (IADE) under the supervision of a MAR. This predominance was also reported by Bonkoungou et al. in Burkina-Faso in 2017, Diango et al. in 2013 in Mali and Chobli et al. in Togo in 2012 with frequencies of 71.60%; 91.90% and 93.71% respectively [<xref ref-type="bibr" rid="scirp.121873-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref29">29</xref>]. This situation could be explained by the low number of anesthesiologists in sub-Saharan Africa in general and in Benin in particular.</p><p>Evolutionary data</p><p>- Maternal data: Bradycardia, tachycardia, arterial hypotension and hypertension</p><p>In our series, bradycardia occurred in 2.94% of the cases and would be due either to AR or to a side effect of the vasopressors used. A significant difference was found between the two groups with a P value &lt; 0.001. The mean number of bradycardia was 0.07 and 0.02 in the NA and E groups, respectively. El Shafei et al. in 2015 in a comparative study between Noradrenaline and Ephedrine in patients with coronary artery disease had found that Noradrenaline is more effective than Ephedrine in maintaining BP with reduction in HR, which is beneficial in patients with coronary artery disease. Thus, they found a mean number of 3 in the norepinephrine group versus 0 in the ephedrine group [<xref ref-type="bibr" rid="scirp.121873-ref30">30</xref>]. Ali Elnabtity et al. in 2018 reported a mean number of 1 in the norepinephrine group, with no incidence in the second group [<xref ref-type="bibr" rid="scirp.121873-ref19">19</xref>]. This bradycardia observed in these different studies could be explained on the one hand by the pharmacological effect of Bupivacaine on calcium and potassium channels with effects on contractility and cardiac arrhythmias, and on the other hand by the direct actions of β1-adrenergic stimulation of Noradrenaline that may increase the heart rate, but this is maintained due to an overall neutral state due to reflex bradycardia by α-adrenergic stimulation.</p><p>- Tachycardia</p><p>The frequency of tachycardia was 24.51%. A significant difference was found between the two groups with a P value &lt; 0.001. The mean number of tachycardia was 0.25 and 0.64 in the NA and E groups, respectively. This result was close to that of Ali Elnabtity et al., who also reported low incidences of tachycardia. In the E group, the mean number was 1 versus 0 in the NA group [<xref ref-type="bibr" rid="scirp.121873-ref19">19</xref>]. Indeed, Ephedrine is a synthetic sympathicomimetic, acting as an indirect agonist of β1 adrenergic receptors and to a much lesser degree of α-receptors; thus, it leads to the release of endogenous norepinephrine by the postganglionic nerve endings of the orthosympathetic system. This explains why it increases the heart rate [<xref ref-type="bibr" rid="scirp.121873-ref31">31</xref>].</p><p>- Arterial hypotension</p><p>The mean number of hypo BP episodes in this study was 0.22 and 0.92 for the NA and E groups respectively; there was a significant difference with a P value &lt; 0.001. El Shafei et al. reported a mean number of 10 in the ephedrine group versus 6 in the norepinephrine group [<xref ref-type="bibr" rid="scirp.121873-ref30">30</xref>], Ali Elnabtity et al. and Hassani et al. reported a mean of 3 and 1.25 respectively in the ephedrine group versus 1 in the norepinephrine group [<xref ref-type="bibr" rid="scirp.121873-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref32">32</xref>]. This higher incidence in the E group is explained by the slow onset of action of ephedrine compared to norepinephrine, allowing hypotension to occur more frequently. This shows that NA is more effective. In contrast to our results and those of these authors, Erkinaro et al. did not report a significant difference between the two groups in the maintenance of blood pressure with 10% for the Ephedrine group and 9% for the Phenylephrine group [<xref ref-type="bibr" rid="scirp.121873-ref33">33</xref>].</p><p>- Arterial hypertension</p><p>The mean number of occurrences of hypertension found in our series was 0.05 in the NA group and 0.15 in the E group. Ali Elnabtity et al. had reported a mean of high blood pressure: 2 in the Ephedrine group versus 1 in the Noradrenaline group [<xref ref-type="bibr" rid="scirp.121873-ref19">19</xref>]. This increases in blood pressure in the E group can be attributed to a side effect of Ephedrine still referred to as dose-dependent reactive hypertension, and this is when the dose of Ephedrine is greater than or equal to 30 mg [<xref ref-type="bibr" rid="scirp.121873-ref31">31</xref>]. This finding highlights the superiority of the quality of Noradrenaline over Ephedrine.</p><p>&#183; Additional Bolus</p><p>Additional boli in the study were a function of the onset of arterial hypotension. They were 19.60% in the NA group versus 57.84% in the E group. Thus, we noted a significant difference between the two groups, explained by the α-adrenergic effect and the weak β-adrenergic effect of Noradrenaline to maintain BP. This, once again, demonstrates the superiority of Noradrenaline in terms of consumption. Ali Elnabtity et al. had made the same finding but with a lower frequency, 3.27% and 4.92% for the NA and E groups, respectively [<xref ref-type="bibr" rid="scirp.121873-ref19">19</xref>].</p><p>- Observed side effects</p><p>With regard to the side effects observed, nausea was more frequently observed in the NA group (53.57%) than in the E group (46.43%). This finding could be explained pharmacologically by the antiemetic effect of Ephedrine [<xref ref-type="bibr" rid="scirp.121873-ref34">34</xref>].</p><p>Factors associated with arterial hypotension</p><p>- Arterial hypotension and systolic blood pressure before induction</p><p>In the present series of studies, pre-induction SBP was associated with the occurrence of arterial hypotension (P = 0.008). Indeed, those who had a PAS lower than 125 mm Hg before induction had more episodes of hypotension. This finding was also made by Fakherpour et al. in 2018 [<xref ref-type="bibr" rid="scirp.121873-ref35">35</xref>] and could be explained by the fact that sympatholysis related to spinal anaesthesia would occur in terrain where the capacity to activate a sympathetic system in a very rapid manner could be impaired. These patients would then be at greater risk of arterial hypotension.</p><p>- Arterial hypotension and body mass index</p><p>A BMI ≥ 30 kg/m<sup>2</sup> was a factor associated with the occurrence of arterial hypotension in this study (P = 0.017). This relationship is also found in the literature, but the threshold for which the risk exists varies between 25 kg/m<sup>2</sup> and 30 kg/m<sup>2</sup> [<xref ref-type="bibr" rid="scirp.121873-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.121873-ref36">36</xref>]. We can therefore suggest that there is a tendency for obese people to have low blood pressure. Some studies also reveal an association between weight gain during pregnancy and the occurrence of hypotension after spinal anaesthesia. This is the case of the 2018 study by Fakherpour et al., which showed a statistical association for weight gain of 11 to 20 kg [<xref ref-type="bibr" rid="scirp.121873-ref26">26</xref>]. This result on obesity could be due to insufficient dosage of initial vasopressor amines. Indeed, these are not administered according to the patient’s weight. The dosage of amines may be insufficient in obese patients because of a larger volume of distribution, which may increase the incidence of arterial hypotension.</p><p>- Arterial Hypotension and Induction-Incision Time</p><p>The time between induction of spinal anesthesia and incision appears in the present study to be a factor associated with the occurrence of hypotension. Indeed, a delay of more than 15 minutes increases the risk of occurrence of arterial hypotension (RP = 1.62 95% CI [1.15 - 2.29] (P = 0.015). This makes perfect sense that the longer the delay between induction and incision, the higher the probability of occurrence of arterial hypotension would be. One hypothesis could be that the occurrence of arterial hypotension is frequently at the time of initiation of the sympathetic block, when the patient’s compensatory mechanisms have not yet been brought into play. It would be interesting to promote an effort of rapidity of the intervening parties: obstetrician.</p></sec><sec id="s5"><title>5. Limitations of the Study</title><p>Our study has some limitations. On the one hand, the small number of parturients does not allow establishing a good correlation between the results. On the other hand, the execution of the protocol was done by several rotating teams whose practices differ from one team to another, with the exception of the doses of ephedrine and noradrenaline which were imposed on each team.</p></sec><sec id="s6"><title>6. Conclusion</title><p>Spinal anesthesia is an anesthetic technique which has established itself over time as the best anesthesiological management for Caesarean sections. The only disadvantage is the hypotension it induces due to its pharmacological effects. It appears from this study that Noradrenaline is more effective than Ephedrine in the prevention and treatment of spinal anesthesia-induced hypotension during caesarean section with a maintained heart rate. The adoption of this product and the protocol for the prevention and treatment of hypotension is necessary to reduce the serious complications that are often responsible for death.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Tchaou, B.A., Massaoul&#233;, S.B., Oriane, D.B.M. and Yapo, B. (2022) Management of Arterial Hypotension Induced by Spinal Anesthesia during Cesarean Section at the Parakou University Hospital in Benin in 2020: Ephedrine versus Noradrenaline. Open Journal of Anesthesiology, 12, 351-367. https://doi.org/10.4236/ojanes.2022.1212031</p></sec></body><back><ref-list><title>References</title><ref id="scirp.121873-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Gouez, A.L., Martel-Jacob, S. and Dermoch, F. (2011) Vasopresseurs pour césarienne urgente et programmée. https://sofia.medicalistes.fr/spip/IMG/pdf/Vasopresseurs_pour_cesarienne_urgente_et_programmee.pdf</mixed-citation></ref><ref id="scirp.121873-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Société Franaise d’Anesthésie et Réanimation. Anesthésie pour césarienne. https://sofia.medicalistes.fr/spip/IMG/pdf/Anesthesie_pour_cesarienne-2.pdf</mixed-citation></ref><ref id="scirp.121873-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Riley, E.T., Cohen, S.E., Macario, A., Desai, J.B. and Ratner, E.F. (1995) Spinal Versus Epidural Anesthesia for Cesarean Section: A Comparison of Time Efficiency, Costs, Charges, and Complications. Anesthesia &amp; Analgesia, 80, 709-712. https://doi.org/10.1097/00000539-199504000-00010</mixed-citation></ref><ref id="scirp.121873-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Chassard, D.B.L. (2015) Anesthésie pour césarienne. Anesthésie &amp; Réanimation, 1, 8-10. https://doi.org/10.1016/j.anrea.2015.01.001</mixed-citation></ref><ref id="scirp.121873-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Langeseater, E.D.R. (2011) Maternal Haemodynamic Changes during Spinal Anesthesia for Cesarean Section. Current Opinion in Anesthesiology, 3, 242-248. https://doi.org/10.1097/ACO.0b013e32834588c5</mixed-citation></ref><ref id="scirp.121873-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Onwochei, D.N., Ngan Kee, W.D., Fung, L., et al. (2017) Norepinephrine Intermittent Intravenous Boluses to Prevent Hypotension during Spinal Anesthesia for Cesarean Delivery: A Sequential Allocation Dose-Finding Study. Anesthesia &amp; Analgesia, 125, 212-218. https://doi.org/10.1213/ANE.0000000000001846</mixed-citation></ref><ref id="scirp.121873-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Mercier, F.J., Bonnet, M.P., De la Dorie, A., et al. (2007) Rachianesthésie pour césarienne: Remplissage, vasopresseurs et hypotension. Annales Franaises d’Anesthésie et de Réanimation, 26, 688-693. https://doi.org/10.1016/j.annfar.2007.05.003</mixed-citation></ref><ref id="scirp.121873-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Ngan Kee, W.D., Khaw, K.S., Tan, P.E., et al. (2009) Placental Transfer and Fetal Metabolic Effects of Phenylephrine and Ephedrine during Spinal Anesthesia for Cesarean Delivery. Anesthesiology, 111, 506-512. https://doi.org/10.1097/ALN.0b013e3181b160a3</mixed-citation></ref><ref id="scirp.121873-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Mercier, F.J., Hoffmann, C., Military, P., et al. (2012) Maternal Hypotension during Spinal Anesthesia for Caesarean Delivery. Minerva Anestesiologica, 79, 62-73.</mixed-citation></ref><ref id="scirp.121873-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Kinsella, S.M., Carvalho, B., Dyer, R.A., et al. (2017) International Consensus Statement on the Management of Hypotension with Vasopressors during Caesarean Section under Spinal Anaesthesia. Anaesthesia, 73, 1-22. https://doi.org/10.1111/anae.14080</mixed-citation></ref><ref id="scirp.121873-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Veeser, M., Hofmann, T., Roth, R., et al. (2012) Vasopressors for the Management of Hypotension after Spinal Anesthesia for Elective Caesarean Section. Systematic Review and Cumulative Meta-Analysis. Acta Anaesthesiologica Scandinavica, 56, 810-816. https://doi.org/10.1111/j.1399-6576.2011.02646.x</mixed-citation></ref><ref id="scirp.121873-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Tan, P.E., Sc, B., Phil, M. and Khaw, K.S. (2015) Randomized Double-Blinded Comparison of Norepinephrine and Phenylephrine for Maintenance. Anesthesiology, 122, 736-745. https://doi.org/10.1097/ALN.0000000000000601</mixed-citation></ref><ref id="scirp.121873-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Dong, L., Dong, Q., Song, X., Liu, Y. and Wang, Y. (2017) Comparison of Prophylactic Bolus Norepinephrine and Phenylephrine on Hypotension during Spinal Anesthesia for Cesarean Section. International Journal of Clinical and Experimental Medicine, 10, 12315-12321.</mixed-citation></ref><ref id="scirp.121873-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Sharkey, A.M., Siddiqui, N., Downey, K., et al. (2018) Comparison of Intermittent Intravenous Boluses of Phenylephrine and Norepinephrine to Prevent and Treat Spinal-Induced Hypotension in Cesarean Deliveries: Randomized Controlled Trial. Anesthesia &amp; Analgesia, 129, 1312-1318. https://doi.org/10.1213/ANE.0000000000003704</mixed-citation></ref><ref id="scirp.121873-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Puthenveettil, Swethan Sivachalam SRP (2019) Comparison of Norepinephrine and Phenylephrine Boluses for the Treatment of Hypotension during Spinal Anaesthesia for Caesarean Section—A Randomised Controlled Trial. Indian Journal of Anaesthesia, 63, 995-1000. https://doi.org/10.4103/ija.IJA_481_19</mixed-citation></ref><ref id="scirp.121873-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Salifou, K. and Chobli, M. (2015) Les Urgences Obstétricales à L’H&amp;ocirc;pital Universitaire de Parakou Au Bénin: Aspects Cliniques, Thérapeutiques et évolutifs. European Scientific Journal, 11, 260-272.</mixed-citation></ref><ref id="scirp.121873-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Beloeil, H. and Mazoit, J. (2010) Pharmacologie des anesthésiques locaux. Anesthésie-Réanimation, 7, 1-18. https://doi.org/10.1016/S0246-0289(10)44745-3</mixed-citation></ref><ref id="scirp.121873-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Dyer, R.A., Reed, A.R., Van Dyk, D., et al. (2009) Hemodynamic Effects of Ephedrine, Phenylephrine, and the Coadministration of Phenylephrine with Oxytocin during Spinal Anesthesia for Elective Cesarean Delivery. Anesthesiology, 111, 753-765. https://doi.org/10.1097/ALN.0b013e3181b437e0</mixed-citation></ref><ref id="scirp.121873-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Mohamed, A., Elnabtity, A., et al. (2018) Norepinephrine versus Ephedrine to Maintain Arterial Blood Pressure during Spinal Anesthesia for Cesarean Delivery: A Prospective Double-Blinded Trial. Anesthesia: Essays and Researches, 12, 92-97. https://doi.org/10.4103/aer.AER_204_17</mixed-citation></ref><ref id="scirp.121873-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Lecoq, J.P.H., Brichant, J.F., Lamy, M.L. and Joris, J.L. (2010) Norepinephrine and Ephedrine Do Not Counteract the Increase in Cutaneous Microcirculation Induced by Spinal Anaesthesia. British Journal of Anaesthesia, 105, 214-219. https://doi.org/10.1093/bja/aeq145</mixed-citation></ref><ref id="scirp.121873-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Dembélé, A., Diango, M., Mangané, M. and Tall, F.K.C. (2013) Activités anesthésiques à la clinique médico-chirurgicale et de réanimation Pasteur à Bamako. Société d’Anesthésie-Réanimation d’Afrique Francoph, 18, 1-8.</mixed-citation></ref><ref id="scirp.121873-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Bordes, J., Esnault, P., Cungi, P.-J., Barbier, N., Sautet, F.V.L., et al. (2015) Déclaration informatisée des évènements indésirables: Un outil pour les comités de retour d’expérience en anesthésie. Anesthésie &amp; Réanimation, 1, 547-553. https://doi.org/10.1016/j.anrea.2015.06.002</mixed-citation></ref><ref id="scirp.121873-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Wang, X., Mao, M., Liu, S., Xu, S. and Yang, J. (2019) A Comparative Study of Bolus Norepinephrine, Phenylephrine, and Ephedrine for the Treatment of Maternal Hypotension in Parturients with Preeclampsia during Cesarean Delivery under Spinal Anesthesia. Medical Science Monitor, 25, 1093-1101. https://doi.org/10.12659/MSM.914143</mixed-citation></ref><ref id="scirp.121873-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Vallejo, M.C., Attaallah, A.F., Elzamzamy, O.M., et al. (2017) An Open-Label Randomized Controlled Clinical Trial for Comparison of Continuous Phenylephrine versus Norepinephrine Infusion in Prevention of Spinal Hypotension during Cesarean Delivery. International Journal of Obstetric Anesthesia, 29, 18-25. https://doi.org/10.1016/j.ijoa.2016.08.005</mixed-citation></ref><ref id="scirp.121873-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Aveline, C. (2013) Rachianesthésie: Essentiel en 2013. Actas SFAR. 1-57.https://sofia.medicalistes.fr/spip/IMG/pdf/rachianesthesie_essentiel_en_2013.pdf</mixed-citation></ref><ref id="scirp.121873-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Cooper, D.W., Carpenter, M., Mowbray, P., et al. (2002) Fetal and Maternal Effects of Phenylephrine and Ephedrine during Spinal Anesthesia for Cesarean Delivery. Anesthesiology, 97, 1582-1590. https://doi.org/10.1097/00000542-200212000-00034</mixed-citation></ref><ref id="scirp.121873-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Khosravi, F., Alishahi, M. and Khanchemehr, Y. (2019) A Comparison between the Effects of Preloading with Ringer’s Solution and Voluven on Hemodynamic Changes in Patients Undergoing Elective Cesarean Section under Spinal Anesthesia. Medical Archives, 73, 44-48. https://doi.org/10.5455/medarh.2019.73.44-48</mixed-citation></ref><ref id="scirp.121873-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Chobli, M., Tomta, K., Mouzou, T. and Sama, H.A.S. (2012) Pratique anesthésique au Togo. Société d’Anesthésie-Réanimation d’Afrique Francoph, 17, 1-13.</mixed-citation></ref><ref id="scirp.121873-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Diango, M., Mangané, M., Dembélé, A., et al. (2013) Incidents et accidents anesthésiques (IAA) en chirurgie orthopédique et traumatologique au CHU Gabriel Touré à Bamako. Société d’Anesthésie-Réanimation d’Afrique Francoph, 18, 1-7.</mixed-citation></ref><ref id="scirp.121873-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">El Fawy, D., El Shafei, M. and El Gendy, H. (2015) Norepinephrine versus Ephedrine for the Prevention of Spinal Anesthesia-Induced Hypotension in Coronary Artery Disease Patients Undergoing Knee Arthroscopy. Ain-Shams Journal of Anesthesiology, 8, 424-428. https://doi.org/10.4103/1687-7934.161723</mixed-citation></ref><ref id="scirp.121873-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Le Gouez, A., Sylvie, M. and Dermoch, F. (2011) Vasopresseurs pour césarienne urgente et programmée. Mapar. 515-526.https://www.google.com/search?ei=zHuyX6DOBpDzgQbXxa6QCQ&amp;q=Le+Gouez+A%2C+Sylvie+M%2C+Dermoch+F.+Vasopresseur</mixed-citation></ref><ref id="scirp.121873-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Hassani, V., Movaseghi, G., Safaeeyan, R., et al. (2018) Comparison of Ephedrine vs. Norepinephrine in Treating Anesthesia-Induced Hypotension in Hypertensive Patients: Randomized Double-Blinded Study. Anesthesia and Pain Medicine, 8, e79626. https://doi.org/10.5812/aapm.79626</mixed-citation></ref><ref id="scirp.121873-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Erkinaro, T., Kavasmaa, T., P&amp;auml;kkil&amp;auml;, M., et al. (2006) Ephedrine and Phenylephrine for the Treatment of Maternal Hypotension in a Chronic Sheep Model of Increased Placental Vascular Resistance. British Journal of Anaesthesia, 96, 231-237. https://doi.org/10.1093/bja/aei305</mixed-citation></ref><ref id="scirp.121873-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Diemunsch, P.S.E. (2009) Rachianesthésie pour césarienne. In: Anesthésie-réanimation obstétricale, Masson, Paris, 100.</mixed-citation></ref><ref id="scirp.121873-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Fakherpour, A., Ghaem, H., et al. (2018) Maternal and Anesthesia Related Risk Factors and Incidence of Spinal Anesthesia Induced Hypotension in Elective Cesarean Section: A Multinomial Logistic Regression. Journal of Anesthesia, 62, 36-46. https://doi.org/10.4103/ija.IJA_416_17</mixed-citation></ref><ref id="scirp.121873-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Gibbs, M., VanDyk, D. and Dyer, R. (2018) Managing Spinal Hypotension during Caesarean Section: An Update. South African Medical Journal, 108, 460-463. https://doi.org/10.7196/SAMJ.2018.v108i6.13373</mixed-citation></ref></ref-list></back></article>